Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
admin 16th September 2019 Uncategorised 0Kyprolis looks poised to break the blockbuster barrier, and combo data with multiple myeloma’s hottest drug could help boost it further. Adding J&J’s Darzalex to Kyprolis and dexamethasone cut patients’ risk of disease progression or death by 37%. More: Amgen's
read more